What this means
This study is still recruiting people. It will look at needs of older adults during chemotherapy and tailor care plans. No results have been posted yet, so we do not know what it found.
Plain-English summary written by an AI model from the registry listing.
- Status
- Recruiting
- Who can join
- Ages 65 and over
- Where
- 2 sites, including North Carolina
The science
- Registered title
- Resilience Enhancement Using Electronic Frailty Index-Directed Care Pathway
- Trial ID
- NCT07175376 ↗
- Phase
- Not applicable
- Study type
- interventional
- Conditions
- Cancer, Frail, Chemotherapy
- What is tested
- Supportive Care
- Sponsor
- Wake Forest University Health Sciences
- Ages
- 65 Years to no maximum
- Dates
- First posted Sep 16, 2025 · updated Jul 2, 2026
Registry summary
The study purpose is to gain a better understanding of the needs of adults aged 65 and older while they are receiving chemotherapy by measuring their resilience and tailor care plans based on their individual needs.
Sites (2)
- Levine Cancer Institute, Charlotte, North Carolina, United States
- Atrium Health Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem, North Carolina, United States
